Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma

Title
Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma
Authors
Keywords
Hepatocellular carcinoma, Cortactin, Neoplasm invasiveness, Prognosis
Journal
World Journal of Surgical Oncology
Volume 11, Issue 1, Pages 74
Publisher
Springer Nature
Online
2013-03-21
DOI
10.1186/1477-7819-11-74

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation